Publication | Open Access

Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option

Breast OncologyMedicineBreast Cancer CellsPharmacology-Phosphoprotein InteractionCancer BiologyBreast CancerConcept StudyAnti-cancer AgentCancer TreatmentOncologyCell BiologyTumor Biology